HGF and liver disorder: MSCs attenuate fibrosis by upregulating hepatocyte growth factor (HGF) (174, 175), insulin growth factor (176), and MSCs-derived EVs improve hepatocyte regeneration and modulate immune activity, demonstrating therapeutic benefits in various liver diseases (173).